Page 2 - Indoco Remedies

Indoco Remedies slips 12% on warning letter from USFDA for Goa plant

The company will respond to the WL within stipulated time and is already working with CGMP consultant to ensure that the remediation activities are completed in line with the USFDA's expectations.

Indoco Remedies surges 43% in two days as Goa plant clears USFDA inspection

The stock surged 20% to Rs 239 on the NSE in early morning trade on Monday, rallying 43% in past two trading sessions.

Indoco Remedies zooms 20% as Goa plant clears USFDA inspection

The stock is locked in upper circuit of 20% at Rs 206 on the BSE after the US health regulator cleared inspection of the company's Goa plant II & III with two minor observations.

Indoco Remedies falls over 15% on import alert for Goa unit

The stock tanked 16% to Rs 208.50, also its 52-week low on the NSE in early morning trade

Indoco Remedies gains over 5% on acquisition of unit at Baddi

The stock up 6% to Rs 349 after the company announced it has acquired the manufacturing facility of Micro Labs located at Baddi.

Indoco Remedies surges on USFDA nod for Goa facility

The moved higher by 15% to Rs 305 on the BSE.

Indoco Remedies rallies on USFDA nod for plant in Goa

The stock has rallied 19% to Rs 314 after the company received USFDA approval for Goa solid dosages plant